Krystal Biotech
KRYS
KRYS
183 hedge funds and large institutions have $2.71B invested in Krystal Biotech in 2023 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 60 increasing their positions, 63 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
14% more funds holding
Funds holding: 160 → 183 (+23)
7.92% more ownership
Funds ownership: 81.44% → 89.36% (+7.9%)
5% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 63
Holders
183
Holding in Top 10
6
Calls
$26M
Puts
$20M
Top Buyers
| 1 | +$95.2M | |
| 2 | +$76.7M | |
| 3 | +$59.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$56.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$36.9M |
Top Sellers
| 1 | -$25M | |
| 2 | -$23.8M | |
| 3 | -$19.4M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$15.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$14.4M |